Average Co-Inventor Count = 9.79
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (10 from 378 patents)
2. Bayer Aktiengesellschaft (6 from 12,160 patents)
3. Bayer Intellectual Property Gmbh (3 from 721 patents)
4. The Broad Institute, Inc. (1 from 443 patents)
16 patents:
1. 12398120 - Substituted hydantoinamides as ADAMTS7 antagonists
2. 11667675 - MASP inhibitory compounds and uses thereof
3. 11337973 - Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitors
4. 10722501 - Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof
5. 10300062 - Bicyclically substituted uracils and the use thereof
6. 9949977 - Bicyclically substituted uracils and the use thereof
7. 9949978 - Bicyclically substituted uracils and the use thereof
8. 9751843 - Substituted uracils and use thereof
9. 9695131 - Substituted uracils as chymase inhibitors
10. 9481672 - Bicyclically substituted uracils and the use thereof
11. 9051323 - Substituted imidazopyrimidines and triazolopyrimidines
12. 8987248 - Substituted piperidines as Par-1 antagonists
13. 8273752 - Substituted imidazopyrimidines and triazolopyrimidines
14. 8119663 - Heteroaryl-substituted piperidines
15. 6835381 - Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor